Abstract
AIMS: The main Aim of the study is to evaluate the impact of clinical pharmacist care in improving glycemic control, HRQOL, medication adherence in type 2 Diabetes mellitus patients. METHODS: The study is conducted in government general hospital, Guntur, a territory care hospital and it is a prospective comparative observational study including 100 subjects with type 2 diabetes mellitus out of these 50 were randomly assigned in to test group and 50 in to the control group. RESULTS: By observing the data, glycaemic control in the test population is clearly improved with a mean difference of -57.18 and p value of < 0.0001 i.e.., extremely significant when compared to the control population with a mean difference of -7.68 and p value of 0.8694 i.e.., nil significant. There is better glycaemic control with respect to the HbA1c levels in the test population with a mean difference of 1.8 and p value of < 0.0001 i.e.., extremely significant than the control population with a mean difference of 7.68 and p value of 0.216 i.e.., nil significant. There is a predominant improvement in quality of life of test population with a mean difference in QOL score 32.81±0.9045 and p value <0.0001 i.e.., statistically extremely significant when compared to the control percentage score with a mean difference of 7.647±1.545 and p value < 0.01 i.e.., statistically significant. There is major increase in medication adherence in the test group with a mean difference of 4.3±0.603 and p value < 0.0001 i.e.., extremely significant when compared to the control with a mean difference of 1.2±0.15 and p value < 0.549 which is statistically nil significant. CONCLUSION: The study provide information regarding impact of glycemic control on QOL and medication adherence in type 2 DM patients. We conclude that clinical pharmacist together with physician play a major role in improving the glycaemic control and medication adherence in type 2 DM patients which directly shows impact on health related quality of life.
